Early peak temperature and mortality in critically ill patients with or without infection
- 1.3k Downloads
To determine whether fever is associated with an increased or decreased risk of death in patients admitted to an intensive care unit (ICU) with infection.
We evaluated the independent association between peak temperature in the first 24 h after ICU admission and in-hospital mortality according to whether there was an admission diagnosis of infection using a database of admissions to 129 ICUs in Australia and New Zealand (ANZ) (n = 269,078). Subsequently, we sought to confirm or refute the ANZ database findings using a validation cohort of admissions to 201 ICUs in the UK (n = 366,973).
A total of 29,083/269,078 (10.8%) ANZ patients and 103,191/366,973 (28.1%) of UK patients were categorised as having an infection. In the ANZ cohort, adjusted in-hospital mortality risk progressively decreased with increasing peak temperature in patients with infection. Relative to the risk at 36.5–36.9°C, the lowest risk was at 39–39.4°C (adjusted OR 0.56; 95% CI 0.48–0.66). In patients without infection, the adjusted mortality risk progressively increased above 39.0°C (adjusted OR 2.07 at 40.0°C or above; 95% CI 1.68–2.55). In the UK cohort, findings were similar with adjusted odds ratios at corresponding temperatures of 0.77 (95% CI 0.71–0.85) and 1.94 (95% CI 1.60–2.34) for infection and non-infection groups, respectively.
Elevated peak temperature in the first 24 h in ICU is associated with decreased in-hospital mortality in critically ill patients with an infection; randomised trials are needed to determine whether controlling fever increases mortality in such patients.
KeywordsInfection Fever Body temperature Antipyresis
We would like to thank Prof. John Kellum and Prof. Michael Reade for offering their feedback and suggestions on this manuscript. This study was funded by the Australian and New Zealand Intensive Care Research Centre, Melbourne, Australia and the Intensive Care National Audit & Research Centre, London, UK.
- 2.Kluger MJ (1979) Fever: its biology, evolution and function. Princeton University Press, New Jersey, p 224Google Scholar
- 4.Bennett AE, Person JP, Simmons EE (1936) Treatment of chronic meningococcic infections in artificial fever. Arch Phys Ther 17:743–748Google Scholar
- 6.Wagner-Jauregg J (1919) Uber die Einwirkung der Malaria auf die progressive Paralyse. Psychiat-Neurol Wchnschr 20:251–255Google Scholar
- 13.Greisman SE (1997) Cardiovascular alterations during fever. In: Mackowiak PA (ed) Fever: basic mechanisms and management, 2nd edn. Lippincott-Raven, Philadelphia, pp 143–165Google Scholar
- 18.Stow PJ, Hart GK, Higlett T, George C, Herkes R, McWilliam D, Bellomo R, for the ANZICS Database Management Committee (2006) Development and implementation of a high quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database. J Crit Care 21:133PubMedCrossRefGoogle Scholar
- 29.Moench M (1926) A study of the heat sensitivity of the meningococcus in vitro within the range of therapeutic temperatures. J Lab Clin Med 57:665–676Google Scholar